TREND1
10 years ago
(Reuters) - Dublin-based Shire Plc (SHP.L), whose proposed sale to AbbVie Inc (ABBV.N) fell apart in October, is considering an offer for U.S-based drug developer NPS Pharmaceuticals Inc (NPSP.O), Bloomberg reported, citing people familiar with the matter.
NPS's shares rose as much as 23 percent to $37.50 (23.9 pounds) on the Nasdaq. Shire's shares were up 1.3 percent on the London Stock Exchange.
The timing of a possible bid would depend on whether the U.S. Food and Drug Administration approves NPS's hormone replacement therapy Natpara, two of the people told Bloomberg.
Natpara is designed to treat low levels of the parathyroid hormone (PTH), which causes hypoparathyroidism.
The FDA is expected to decide on the drug on Jan. 24, 2015.
If approved, NPS plans to launch Natpara in the second quarter of 2015.
Although NPS is high on Shire's list of potential deals, other targets are also being considered, Bloomberg said.
Shire and NPS were not immediately available for comment.
AbbVie pulled the plug on its plan to buy Shire, blaming new U.S. tax rules aimed at curtailing tax inversion deals.
(Reporting by Devika Krishna Kumar in Bengaluru; Editing by Siddharth Cavale)
stocktrademan
10 years ago
$NPSP DD Notes ~ http://www.ddnotesmaker.com/NPSP
bullish
long term buy and hold
$NPSP recent news/filings
## source: finance.yahoo.com
Wed, 17 Dec 2014 17:10:32 GMT ~ Shire considering bid for NPS Pharmaceuticals - Bloomberg
read full: http://sg.finance.yahoo.com/news/shire-considering-bid-nps-pharmaceuticals-171032573.html
*********************************************************
Wed, 17 Dec 2014 17:06:10 GMT ~ Shire considering bid for NPS Pharmaceuticals - Bloomberg
[Reuters - UK Focus] - Dublin-based Shire Plc, whose proposed sale to AbbVie Inc fell apart in October, is considering an offer for U.S-based drug developer NPS Pharmaceuticals Inc, Bloomberg reported, citing people familiar ...
read full: http://uk.finance.yahoo.com/news/shire-considering-bid-nps-pharmaceuticals-170610879.html
*********************************************************
Wed, 17 Dec 2014 17:06:10 GMT ~ Shire considering bid for NPS Pharmaceuticals - Bloomberg
[Reuters] - Dublin-based Shire Plc, whose proposed sale to AbbVie Inc fell apart in October, is considering an offer for U.S-based drug developer NPS Pharmaceuticals Inc, Bloomberg reported, citing people familiar ...
read full: http://finance.yahoo.com/news/shire-considering-bid-nps-pharmaceuticals-170610029.html
*********************************************************
Wed, 17 Dec 2014 16:44:18 GMT ~ BUZZ-NPS Pharma Inc: Shire considering bid - Bloomberg
[Reuters - UK Focus] - ** Shire Plc considering bid for NPS Pharmaceuticals Inc, Bloomberg reports ** U.S. biopharma company NPS's shares up 21.3 pct at $36.95 in heavy trading ** Ireland-based Shire's shares up 1.9 pct at $212.64 ...
read full: http://uk.finance.yahoo.com/news/buzz-nps-pharma-inc-shire-164418460.html
*********************************************************
Wed, 17 Dec 2014 16:01:43 GMT ~ Shire Said to Weigh Offer for NPS as It Revisits Deals
read full: http://www.bloomberg.com/news/2014-12-17/shire-said-to-weigh-offer-for-nps-as-it-revisits-deals.html?cmpid=yhoo
*********************************************************
$NPSP charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$NPSP company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/NPSP/company-info
Ticker: $NPSP
OTC Market Place: Not Available
CIK code: 0000890465
Company name: NPS Pharmaceuticals, Inc.
Incorporated In: DE, USA
$NPSP share structure
## source: otcmarkets.com
Market Value: $3,856,913,459 a/o Dec 17, 2014
Shares Outstanding: 106,839,708 a/o Nov 03, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$NPSP extra dd links
Company name: NPS Pharmaceuticals, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NPSP+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NPSP+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NPSP+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NPSP/news - http://finance.yahoo.com/q/h?s=NPSP+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NPSP/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NPSP/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NPSP+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NPSP
DTCC (dtcc.com): http://search2.dtcc.com/?q=NPS+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=NPS+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=NPS+Pharmaceuticals%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NPSP
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000890465&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NPSP/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NPSP/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NPSP&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NPSP
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NPSP/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NPSP+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NPSP+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NPSP
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NPSP
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NPSP+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NPSP/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NPSP+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NPSP.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NPSP
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NPSP/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NPSP
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NPSP
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NPSP:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NPSP
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NPSP
$NPSP DD Notes ~ http://www.ddnotesmaker.com/NPSP
stocktrademan
10 years ago
$NPSP DD Notes ~ http://www.ddnotesmaker.com/NPSP
bullish
nice breakout over long term resistance
moving averages now acting as support
long term bull flag breakout in progress
$NPSP recent news/filings
## source: finance.yahoo.com
Tue, 11 Nov 2014 21:10:00 GMT ~ NPS Pharma to Present at Jefferies Global Healthcare Conference
[Business Wire] - NPS Pharmaceuticals, Inc. is scheduled to present at the Jefferies 2014 Global Healthcare Conference in London on Thursday, November 20, 2014 at 8:00 a.m. WET. The presentation will be available as a live webcast with a replay available approximately three hours after the presentations have concluded.
read full: http://finance.yahoo.com/news/nps-pharma-present-jefferies-global-211000250.html
*********************************************************
Tue, 11 Nov 2014 15:50:02 GMT ~ NPS Pharmaceuticals Incurs Wider Q3 Loss, Revenues Miss
read full: http://finance.yahoo.com/news/nps-pharmaceuticals-incurs-wider-q3-155002778.html
*********************************************************
Mon, 10 Nov 2014 21:39:57 GMT ~ NPS reports 3Q loss
read full: http://sg.finance.yahoo.com/news/nps-reports-3q-loss-213957014--finance.html
*********************************************************
Mon, 10 Nov 2014 21:39:57 GMT ~ NPS reports 3Q loss
read full: http://finance.yahoo.com/news/nps-reports-3q-loss-213957016.html
*********************************************************
Mon, 10 Nov 2014 21:06:44 GMT ~ NPS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
read full: http://biz.yahoo.com/e/141110/npsp8-k.html
*********************************************************
$NPSP charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$NPSP company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/NPSP/company-info
Ticker: $NPSP
OTC Market Place: Not Available
CIK code: 0000890465
Company name: NPS Pharmaceuticals, Inc.
Incorporated In: DE, USA
$NPSP share structure
## source: otcmarkets.com
Market Value: $3,090,283,674 a/o Nov 17, 2014
Shares Outstanding: 106,561,506 a/o Jul 30, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$NPSP extra dd links
Company name: NPS Pharmaceuticals, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NPSP+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NPSP+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NPSP+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NPSP/news - http://finance.yahoo.com/q/h?s=NPSP+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NPSP/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NPSP/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NPSP+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NPSP
DTCC (dtcc.com): http://search2.dtcc.com/?q=NPS+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=NPS+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=NPS+Pharmaceuticals%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NPSP
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000890465&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NPSP/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NPSP/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NPSP&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NPSP
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NPSP/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NPSP+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NPSP+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NPSP
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NPSP
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NPSP+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NPSP/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NPSP+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NPSP.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NPSP
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NPSP/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NPSP/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NPSP
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NPSP
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NPSP:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NPSP
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NPSP
$NPSP DD Notes ~ http://www.ddnotesmaker.com/NPSP
ThatBobGuy
10 years ago
Would be nice to hear something.
This is from Bloomberg all the way back on June 5th...
With drugmakers pursuing deals like never before, Shire Plc (SHP)โs best defense against becoming a target may be to go on the hunt itself.
Reports last week that Shire is weighing a bid for NPS Pharmaceuticals Inc. (NPSP) have pushed that companyโs shares up 20 percent. While NPS said it hasnโt held talks with Shire about a deal, Piper Jaffray Cos. said Shire needs to make purchases if it wants to keep from being gobbled up amid the record $139 billion in pharmaceutical deals that were announced so far this quarter. Dublin-based Shire has been speculated as a takeover candidate because of the $35 billion companyโs Irish tax base and focus on fast-growing rare-disease treatments.
โIf they want to stay independent, then going on a bit of a shopping spree makes it harder for another entity to go after them,โ David Amsellem, a New York-based analyst at Piper Jaffray said in a phone interview. โThey will be approached. They probably have been approached.โ
NPS, a $3.5 billion maker of medicines for short-bowel syndrome and hypoparathyroidism, would be a logical acquisition candidate for Shire because it would bolster the companyโs portfolio of rare-disease drugs, according to Wedbush Inc. Other possible targets for Shire, which has increased its dealmaking the last two years, may include muscular dystrophy drug developers Prosensa Holding NV (RNA) and Sarepta Therapeutics Inc. (SRPT), said Cenkos Securities Plc.
Jessica Mann, a representative for Shire, said the company doesnโt comment on M&A speculation.
Well, Now what???
ThatBobGuy
10 years ago
Well this is rather confusing.
NPSP files an 8-K to dispel rumors of a potential buyout. What are the lawyers going to do now?
- - - - - - - - - - - - - -
Item 7.01 Regulation FD Disclosure.
Although it is generally NPS Pharmaceuticals, Inc.โs (โNPSโ) policy not to comment on media speculation and market rumors, in light of the erroneous press reports that Shire Plc (โShireโ) has had communications with NPS concerning a purported offer by Shire to acquire NPS, NPS confirmed that to date NPS has not had any communication with Shire or any representative of Shire concerning the acquisition of NPS by Shire. NPS intends to continue its policy of not commenting on media speculation and market rumors and undertakes no obligation to update the information contained in this Report.
In accordance with General Instruction B.2 of Form 8-K, the information contained in this Current Report on Form 8-K is being furnished and shall not be deemed โfiledโ for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the โExchange Actโ), or otherwise subject to the liabilities of that Section, and such information shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act unless specifically stated.
- - - - - - - - - - - - - -
The next few days should be interesting.
ThatBobGuy
10 years ago
Here Come the Lawyers...
No offense to any members of the legal profession, but when this stuff happens, you can pretty much bank on this being a done deal.
SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of NPS Pharmaceuticals, Inc. - NPSP
12:34p ET June 2, 2014 (PR NewsWire) Print
Pomerantz LLP is investigating claims on behalf of investors of NPS Pharmaceuticals, Inc. ("NPS Pharmaceuticals" or the "Company") (Nasdaq: NPSP) (ISIN: US62936P1030) (CUSIP: 62936P103) concerning the proposed acquisition of NPS Pharmaceuticals by Shire Plc.
NPS Pharmaceuticals shareholders seeking more information about this acquisition are advised to contact Robert Willoughby at rswilloughby@pomlaw.com or 212-661-1100 or 888-476-6529, ext. 237.
The investigation concerns whether the NPS Pharmaceuticals directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value. Under the terms of the agreement, each share of NPS Pharmaceuticals will be exchanged for $40 in cash. However, the Price to Revenue and Book Value multiples are below comparable transactions' averages, and at least one Analyst set target price of $44 per NPS Pharmaceuticals share.
Pomerantz LLP, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz LLP pioneered the field of securities class actions. Today, more than 75 years later, the Pomerantz LLP continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of defrauded investors. See www.pomerantzlaw.com.
CONTACT: Robert Willoughby Pomerantz LLP 212-661-1100 ext. 237 rswilloughby@pomlaw.com
SOURCE Pomerantz LLP
WID
10 years ago
Buyout Offer Is Much Better Than $40/Share
It looks like the offer will be around $50/share. See story below:
(Reuters) - London-listed drugmaker Shire Plc has secured a $5 billion credit facility for a takeover offer for New-Jersey-based NPS Pharmaceuticals, The Times of London reported on Sunday.
The newspaper said Shire has lined the credit facility for NPS, which is being advised by Goldman Sachs, from banks led by Citigroup. (link.reuters.com/kuk79v)
Insiders told The Times that an initial approach to NPS by Shire has been rebuffed. However, a former London hospital doctor with ties to both companies is acting as a go-between, the daily said.
The Times reported that Colin Broom, who is on the board of NPS and the chief scientific officer of U.S. company ViroPharma that was taken over by Shire last year, would be a key figure in the takeover talks.
The Financial Times blog, Alphaville, was the first to report on Shire considering a bid for NPS Pharma on Friday.
Shire could not be contacted for comment outside of normal business hours.
http://www.reuters.com/article/2014/06/01/us-shire-m-a-nps-idUSKBN0EC1YO20140601
ThatBobGuy
10 years ago
Possible Buyout??
Shares of NPS Pharmaceuticals, a biopharmaceutical company focused on developing therapies to treat rare diseases, skyrocketed as much as 26% after rumors surfaced that it could be the target of a buyout.
According to a report from FT Alphaville, which cited familiar sources, Shire (NASDAQ: SHPG) has held internal talks and has been working with its advisors to possible arrange an all-cash offer for NPS Pharmaceuticals of around $40 per share. If Financial Times' blog is accurate, it would represent a valuation in excess of $4 billion for NPS and place a premium of roughly 50% on the company compared to yesterday's closing price. As of this writing, no comment has been issued by either Shire or NPS concerning the matter
Well, the stock sure jumped today...